| Mrs Sandra L Simone, MS, CCC-SLP | |
|
168 Summerfield Rd, Belvidere, NJ 07823-2714 | |
| (201) 874-8861 | |
| Not Available |
| Full Name | Mrs Sandra L Simone |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 168 Summerfield Rd, Belvidere, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366011918 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Sandra L Simone, MS, CCC-SLP 168 Summerfield Rd, Belvidere, NJ 07823-2714 Ph: (201) 874-8861 | Mrs Sandra L Simone, MS, CCC-SLP 168 Summerfield Rd, Belvidere, NJ 07823-2714 Ph: (201) 874-8861 |
News Archive
S*BIO Pte Ltd today announced that results from a Phase 2 study demonstrated that its JAK2 inhibitor pacritinib (SB1518) effectively reduced splenomegaly in myelofibrosis (MF) patients, with minimal impact on existing cytopenias providing an important therapeutic niche in the treatment of MF. Results were presented at the 53rd ASH Annual Meeting and Exposition in San Diego.
According to a new study even relatively minor health problems seemingly unrelated to the mind may affect a person's risk of dementia, including Alzheimer's disease. This is apart from the other known risk factors like heart disease, strokes and other serious health conditions that affect the circulatory system or brain. The study was published this week in the journal Neurology.
Transposagen Biopharmaceuticals, Inc., based in Lexington, KY, has announced today that it has added 170 genetically modified rats and related biomaterials to its database of laboratory rats with a genetic modification that can mimic a human disease. These animals are used by academic, pharmaceutical, and biotech scientists for drug discovery and development research and will be sold under Transposagen's new TGEM(TM) Rat Models brand.
Abiomed Inc., a leading provider of breakthrough heart support technologies, today announced that the initial clinical data from the safety study for Symphony was presented by Renzo Cecere, M.D., FRCSC, FACS, Associate Professor of Surgery at McGill University, during the late-breaking clinical trials session at the Society of Thoracic Surgeons (STS) 2012 Annual Meeting in Fort Lauderdale, Florida.
The hepatitis C virus hijacks the body's immune system, leaving T cells unable to function. A new study in animal models suggests that blocking a protein that helps the virus thrive could restore immune function, allowing the body to fight infection. The work, led by teams at The Research Institute at Nationwide Children's Hospital and Emory University, was published online Aug. 26 in the Proceedings of the National Academy of Sciences.
› Verified 4 days ago
Rachel Mae Chiara, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 276 Race St, Belvidere, NJ 07823 Phone: 908-235-2987 | |
Catherine Grace Deehan, MA SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Brookfield Dr, Belvidere, NJ 07823 Phone: 908-475-5556 |